Singular Genomics Systems Volatility
| OMICDelisted Stock | USD 20.01 0.00 0.00% |
We have found eighteen technical indicators for Singular Genomics Systems, which you can use to evaluate the volatility of the company. Please validate Singular Genomics' Variance of 2.74, coefficient of variation of (917.80), and Risk Adjusted Performance of (0.08) to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| OMIC |
Based on monthly moving average Singular Genomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Singular Genomics by adding Singular Genomics to a well-diversified portfolio.
Key indicators related to Singular Genomics' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Singular Genomics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Singular daily returns, and it is calculated using variance and standard deviation. We also use Singular's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Singular Genomics volatility.
Singular |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Singular Genomics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Singular Genomics at lower prices to lower their average cost per share. Similarly, when the prices of Singular Genomics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities. Main indicators related to Singular Genomics' market risk premium analysis include:
Beta (0.01) | Alpha (0.19) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Moving together with Singular Stock
Moving against Singular Stock
| 0.72 | GPOVF | Grupo Carso SAB | PairCorr |
| 0.7 | WMT | Walmart Common Stock | PairCorr |
| 0.69 | MRK | Merck Company | PairCorr |
| 0.66 | AA | Alcoa Corp | PairCorr |
| 0.56 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.54 | BA | Boeing | PairCorr |
| 0.54 | BAC | Bank of America | PairCorr |
| 0.51 | MCD | McDonalds Earnings Call Today | PairCorr |
| 0.46 | DD | Dupont De Nemours | PairCorr |
| 0.43 | CAT | Caterpillar | PairCorr |
Singular Genomics Market Sensitivity And Downside Risk
Singular Genomics' beta coefficient measures the volatility of Singular stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Singular stock's returns against your selected market. In other words, Singular Genomics's beta of -0.0071 provides an investor with an approximation of how much risk Singular Genomics stock can potentially add to one of your existing portfolios. Singular Genomics Systems exhibits very low volatility with skewness of -2.06 and kurtosis of 11.28. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Singular Genomics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Singular Genomics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
| α | -0.19 | β | -0.0071 | Check current 90 days Singular Genomics correlation with market (Dow Jones Industrial)
Singular Genomics Volatility and Downside Risk
Singular standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Singular Genomics Systems Stock Volatility Analysis
Volatility refers to the frequency at which Singular Genomics delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Singular Genomics' price changes. Investors will then calculate the volatility of Singular Genomics' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Singular Genomics' volatility:
Historical Volatility
This type of delisted stock volatility measures Singular Genomics' fluctuations based on previous trends. It's commonly used to predict Singular Genomics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Singular Genomics' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Singular Genomics' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Singular Genomics Projected Return Density Against Market
Given the investment horizon of 90 days Singular Genomics Systems has a beta of -0.0071 . This indicates as returns on the benchmark increase, returns on holding Singular Genomics are expected to decrease at a much lower rate. During a bear market, however, Singular Genomics Systems is likely to outperform the market.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Singular Genomics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Singular Genomics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Singular delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Predicted Return Density |
| Returns |
What Drives a Singular Genomics Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Singular Genomics Stock Return Volatility
Singular Genomics historical daily return volatility represents how much of Singular Genomics delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7778% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Singular Stock performing well and Singular Genomics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Singular Genomics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GCTK | 4.99 | (1.82) | 0.00 | (0.48) | 0.00 | 8.36 | 56.93 | |||
| ALVR | 3.08 | (0.19) | 0.00 | 2.32 | 0.00 | 7.14 | 18.20 | |||
| BLUE | 3.75 | 0.61 | 0.15 | 7.40 | 2.89 | 10.28 | 50.85 | |||
| KRON | 2.46 | 0.13 | (0.01) | (0.02) | 3.67 | 4.00 | 32.10 | |||
| EAR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SYRE | 2.68 | 0.53 | 0.19 | 0.48 | 2.48 | 7.15 | 20.03 | |||
| AKYA | 4.10 | 0.27 | 0.03 | (1.56) | 5.25 | 9.73 | 32.35 | |||
| RNTX | 3.66 | (0.50) | 0.00 | (0.32) | 0.00 | 9.52 | 22.23 | |||
| AHG | 3.73 | (0.10) | 0.00 | 0.79 | 0.00 | 11.59 | 26.06 | |||
| SHOT | 9.59 | 1.02 | 0.07 | (3.01) | 11.70 | 29.73 | 86.17 |
About Singular Genomics Volatility
Volatility is a rate at which the price of Singular Genomics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Singular Genomics may increase or decrease. In other words, similar to Singular's beta indicator, it measures the risk of Singular Genomics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Singular Genomics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. Singular Genomics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 248 people.
Singular Genomics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Singular Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Singular Genomics' price varies over time.
3 ways to utilize Singular Genomics' volatility to invest better
Higher Singular Genomics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Singular Genomics Systems stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Singular Genomics Systems stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Singular Genomics Systems investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Singular Genomics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Singular Genomics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Singular Genomics Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.78 and is 9.223372036854776E16 times more volatile than Singular Genomics Systems. 0 percent of all equities and portfolios are less risky than Singular Genomics. You can use Singular Genomics Systems to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Singular Genomics to be traded at $19.81 in 90 days.Excellent diversification
The correlation between Singular Genomics Systems and DJI is -0.64 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and DJI in the same portfolio, assuming nothing else is changed.
Singular Genomics Additional Risk Indicators
The analysis of Singular Genomics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Singular Genomics' investment and either accepting that risk or mitigating it. Along with some common measures of Singular Genomics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | 26.83 | |||
| Mean Deviation | 0.9417 | |||
| Coefficient Of Variation | (917.80) | |||
| Standard Deviation | 1.66 | |||
| Variance | 2.74 | |||
| Information Ratio | (0.16) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Singular Genomics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Singular Genomics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Singular Genomics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Singular Genomics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Singular Genomics Systems.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Singular Stock
If you are still planning to invest in Singular Genomics Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Singular Genomics' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |